Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk

PJ Bingley, EAM Gale, Group European Nicotinamide Diabetes Intervebtion Trial (ENDIT)

Research output: Contribution to journalArticle (Academic Journal)peer-review

86 Citations (Scopus)
Translated title of the contributionProgression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk
Original languageEnglish
Pages (from-to)881 - 890
Number of pages10
JournalDiabetologia
Volume49 (5)
DOIs
Publication statusPublished - May 2006

Bibliographical note

Publisher: Springer

Cite this